Name | Serplulimab |
---|
Description | Serplulimab is humanized monoclonal anti-PD-1 antibody[1]. |
---|---|
Related Catalog | |
References |
[1]. Lee A. Serplulimab: First Approval. Drugs. 2022 Jul;82(10):1137-1141. |
No Any Chemical & Physical Properties |